The “Dinero” supplement of the newspaper La Vanguardia has interviewed Roger Gomis, ICREA researcher at IRB Barcelona, about Inbiomotion, a spin-off from the institute and ICREA. This company, which came about from biomedical research and an entrepreneurial spirit, develops and commercialises a diagnostic test that allows the identification of those breast cancer patients most likely to develop bone metastasis. “It is very satisfying that an idea that arose in a lab has found a favourable environment in Barcelona in which to take a potentially life-saving product onto the market,” says Gomis.
Link to La Vanguardia
The Pfizer Foundation has awarded the IRB Barcelona scientist a prize within the “Basic Research” category.
Gloria Pascual, a member of the Stem Cells and Cancer lab, will receive €10,000 to continue her research
Nació Digital, the Vinos y Restaurantes magazine and Vinetur, have published an article about the collaboration of AT Roca, a winery in Sant Sadurní d'Anoia, through the fundraising wine "Cop de Cor", which the foundation has been producing since 2015. This project aims to support research into cancer and metastasis conducted at IRB Barcelona and increase public awareness of the value of cancer research.
Link to Nació Digital
La Vanguardia has published an opinion article by Roger Gomis, head of the Control of Growth and Cancer Metastasis lab at IRB Barcelona, in the framework of the World Cancer Day. In the article, the researcher gives information about the latest report from the AECC, ASEICA and the la Caixa Foundation. "In recent decades, joint action in prevention, diagnosis, surgery and new therapies has had a notable impact on patient survival, increasing from 20% to 55% today.
